Peginterferon α-2a (Peg-IFN)
Showing 1 - 25 of 4,408
Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)
Not yet recruiting
- Chronic Hepatitis B
- PEG IFN α-2b; TAF
- (no location specified)
Aug 5, 2022
Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)
Completed
- Acute Myeloid Leukemia
- peg-IFN-α
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Oct 1, 2021
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +2 more
- Cemiplimab-Rwlc
- PEG-IFN alfa-2a
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)
Recruiting
- Hepatitis B, Chronic
- ASC42 10mg
- +4 more
-
Guangzhou, Guangdong, ChinaNanFang Hospital of Southern Medical University
Jan 13, 2022
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)
Recruiting
- Adult T-cell Leukemia-Lymphoma
- ATLL
- Belinostat
- +3 more
-
Miami, FloridaUniversity of Miami
Jan 24, 2022
Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)
Completed
- Hepatitis C
- Peginterferon alfa-2a
- +2 more
-
Rotterdam, NetherlandsErasmus Medical Center
Aug 26, 2021
HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)
Unknown status
- HIV
- +2 more
- Pegylated Interferon alpha 2b (peg-IFN-α2b)
- 3BNC117 + 10-1074
-
Philadelphia, Pennsylvania
- +1 more
Jun 22, 2021
Advanced Cholangiocarcinoma Trial in Washington (Pembrolizumab, Sylatron)
Terminated
- Advanced Cholangiocarcinoma
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Feb 14, 2022
Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)
Active, not recruiting
- Hepatitis B, Chronic
- EYP001a
- +2 more
-
Hong Kong, Hong Kong
- +5 more
Sep 27, 2021
Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)
Not yet recruiting
- Hepatitis B, Chronic
- hepalatide
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Tong Ren Hospital
Nov 12, 2021
Chronic Viral Hepatitis B With Delta-agent Trial in Russian Federation (Myrcludex B, PEG IFN alfa-2a, Tenofovir)
Completed
- Chronic Viral Hepatitis B With Delta-agent
- Myrcludex B
- +2 more
-
Chelyabinsk, Russian Federation
- +6 more
Apr 7, 2021
Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,
Recruiting
- Chronic HBV Infection
- Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
- +2 more
-
Beijing, Beijing, China
- +7 more
Feb 23, 2023
Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])
Completed
- Hepatitis B, Chronic
- peginterferon alfa-2a [Pegasys]
-
San Francisco, California
- +38 more
Oct 26, 2022
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Liver Fibrosis Trial (PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil Fumarate)
Not yet recruiting
- Liver Fibrosis
- PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate
- Tenofovir Disoproxil Fumarate
- (no location specified)
Nov 17, 2020
Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)
Not yet recruiting
- Chronic Hepatitis B
- Hepalatide
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Feb 16, 2022
Chronic Hepatitis B Trial in Beijing (PEG-IFN)
Recruiting
- Chronic Hepatitis B
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022
Chronic Hepatitis B Trial in Beijing (PEG-IFN)
Recruiting
- Chronic Hepatitis B
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022
Leukemia, Chronic Myeloid Trial in Malaysia (Peginterferon-a-2a)
Active, not recruiting
- Leukemia, Chronic Myeloid
-
Johor Bahru, Johor, Malaysia
- +8 more
Sep 11, 2020